Volume
Volume, licence 80122976: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Magnum Nutraceuticals Inc.
- NPN or DIN-HM
- 80122976
- Status
- Active licence
- Licence date
- 1 February 2023
- Revision date
- 10 January 2024
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
- Conditions légales
Contains tea (Camellia sinensis). Green tea extracts must provide less than 800 mg of epigallocatechin-3-gallate per daily portion, with mandatory warnings.
annexe III, partie B (règlement (UE) 2022/2340). Regulation (EC) No 1925/2006, latest consolidated version, retrieved 21 October 2026.
- Conditions légales
Brassica oleracea L.: L'étiquetage doit comporter un avertissement recommandant aux personnes ayant une hypothyroïdie ou un traitement de la thyroïde de consulter leur médecin.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Camellia sinensis (L.) Kuntze: Seules sont admises la poudre issue du broyage des feuilles et les préparations obtenues à partir des solvants suivants : l'eau, l'alcool à 25 % (v/v), ainsi que les solvants autorisés pour la décaféination ou la suppression des matières irritantes et amères. Les recommandations d'emploi ne doivent pas conduire à une ingestion quotidienne d'EGCG supérieure à 300 mg. L'étiquetage doit comporter des avertissements déconseillant leur prise en dehors des repas, ainsi que leur consommation par les enfants, les adolescents, les femmes enceintes ou allaitantes.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Brassica oleracea var. viridis Source : Brassica oleracea var. viridis - feuille | 0.05 mg | Not calculated |
| Brassica oleracea var. italica Source : Brassica oleracea var. italica - Sommité (herbe) | 0.05 mg | Not calculated |
| Extrait de fève de café vert Extract : Matériel brut sec Extraction ratio : 12.000:1 Dry plant equivalent : 55.8 mg Potency : 50.0 % Chlorogenic acids | 4.65 mg | Not calculated |
| L-Arginine Source : Arginine silicate inositol | 120.0 mg | Not calculated |
| Punica granatum Source : Punica granatum - fruit Extract : Matériel brut sec Extraction ratio : 4.000:1 Dry plant equivalent : 640 mg | 160.0 mg | Not calculated |
| Camellia sinensis Source : Camellia sinensis - feuille Extract : Matériel brut sec Extraction ratio : 20.000:1 Dry plant equivalent : 93 mg Potency : 40.0 % Epigallocatechin 3-gallate | 4.65 mg | Not calculated |
| Curcuma longa Source : Curcuma longa - rhizome Extract : Matériel brut sec Extraction ratio : 100.000:1 Dry plant equivalent : 50 mg Potency : 80.0 % Curcumin | 0.5 mg | Not calculated |
| Prunus cerasus Source : Prunus cerasus - Fruit | 0.05 mg | Not calculated |
| Pinus pinaster Potency : 90.0 % Proanthocyanidins | 20.0 mg | Not calculated |
| Vaccinium corymbosum Source : Vaccinium corymbosum - Fruit | 0.05 mg | Not calculated |
| 4-(Aminobutyl)guanidine Source : Sulfate d'agmatine | 111.0 mg | Not calculated |
Non-medicinal ingredients
Aluminosilicate de potassium, Bleu FD&C n° 1, Jaune FD&C n° 6, Gélatine, Rouge FD&C No. 3
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18.0 Année(s) | 5.0 Capsule | 1.0 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Source of (an) antioxidant(s)/Provides (an) antioxidant(s) that help(s) fight/protect (cell) against/reduce (the oxidative effect of/the oxidative damage caused by/cell damage caused by) free radicals. Source of (an) antioxidant(s)/Provides (an) antioxidant(s). Provides a substrate for nitric oxide (a vasodilator) production. L-arginine is (a non-essential amino acid) involved in protein synthesis. L-arginine helps support nitric oxide levels.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80122976
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2024. Photograph the packaging to check whether it has changed.
Has the product changed? Photograph the packaging.